查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553482

轉染試劑和儀器市場規模、佔有率、趨勢分析報告：按產品、方法、應用、最終用途、地區和細分市場預測，2024-2030 年

Transfection Reagents & Equipment Market Size, Share & Trends Analysis Report, By Product, By Method (Electroporation), By Application (Transgenic Models), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

轉染試劑及設備市場成長及趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球轉染試劑和儀器市場規模預計將達到21.9億美元，2024年至2030年複合年成長率為7.7%。

與陽離子脂質體相比，基於現代聚合物製劑的化合物對細胞友好，並且這些產品實現了更高的基因轉移效率，進一步促進了市場上獨特轉染產品的開發。

此外，多組分試劑（例如 F. Hoffmann-La Roche AG 的 X-tremeGENE）比傳統的單組分製劑具有更高的效率和最小的細胞毒性。因此，企業熱衷於提供尖端的轉染解決方案，這反過來又為市場成長提供了重要動力。

基因表現研究領域在市場上佔據主導地位，並在 2019 年佔據最大的收益佔有率。這是由於臨床實踐中對基因組資訊翻譯的日益關注。此外，與染色體異常識別相關的研究計劃數量的增加預計將推動該領域的成長。

轉染試劑和設備市場報告亮點

  • 試劑細分市場在轉染試劑和設備市場中佔據主導地位，2023年銷售佔有率最大，為55.4%。
  • 電穿孔產業在 2023 年佔據市場主導地位。從知名公司到新興公司的各種電穿孔解決方案正在推動該領域的成長。
  • 生物醫學研究領域預計在預測期內複合年成長率最快。近年來，利用慢病毒進行轉染在生物醫學研究中受到廣泛關注。
  • 2023年，北美在轉染試劑和設備市場中佔據最大的銷售佔有率。預計該地區在預測期內將繼續這種模式。
  • 市場參與企業熱衷於擴大產品系列以維持市場競爭。
  • 例如，2019年7月，Mirus Bio推出了TransIT-VirusGEN SELECT轉染試劑，旨在用於基因和細胞製造中的藥物發現過程。該材料簡化了臨床前和早期臨床試驗的病毒載體製造中使用的輔助材料的鑑定流程。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章轉染試劑和設備市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 轉染試劑及設備市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 轉染試劑與設備市場：依產品估算與趨勢分析

  • 細分儀表板
  • 轉染試劑和設備市場：2023 年和 2030 年產品變異分析
  • 試劑
  • 裝置

第5章轉染試劑和設備市場：方法估計和趨勢分析

  • 細分儀表板
  • 轉染試劑與設備市場：方法變異分析，2023 年和 2030 年
  • 電穿孔
  • 脂質體
  • 粒子撞擊
  • 顯微注射
  • 腺病毒載體
  • 磷酸鈣
  • DEAE-聚葡萄糖
  • 磁珠
  • 活化的樹狀聚合物
  • 雷射感染

第6章 轉染試劑與設備市場：依應用估算與趨勢分析

  • 細分儀表板
  • 轉染試劑和儀器市場：2023 年和 2030 年應用變化分析
  • 基因表現研究
  • 蛋白質生產
  • 基因改造模型
  • 實施治療
  • 癌症研究
  • 生物醫學研究

第7章 轉染試劑和設備市場：依最終用途分類的估算與趨勢分析

  • 細分儀表板
  • 轉染試劑和設備市場：2023 年和 2030 年最終用途變化分析
  • 學術研究所
  • 製藥和生物技術公司

第8章轉染試劑和設備市場：區域估計和趨勢分析

  • 2023 年和 2030 年按地區分類的轉染試劑和設備
  • 北美洲
    • 2018-2030年北美轉染試劑和設備市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲轉染試劑和設備市場估計與預測
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區轉染試劑和設備市場估計和預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲轉染試劑和設備市場估計與預測
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲轉染試劑和設備市場估計和預測，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Promega Corporation
    • Lonza
    • QIAGEN
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories Inc.
    • Merck KGaA
    • OriGene Technologies Inc
    • MaxCyte, Inc.
    • Polyplus
簡介目錄
Product Code: 978-1-68038-715-5

Transfection Reagents & Equipment Market Growth & Trends:

The global transfection reagents & equipment market size is expected to reach USD 2.19 billion by 2030, registering a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.

Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.

The gene expression studies segment dominated the market and account for the largest revenue share in 2019. This is attributed to the rising focus on the translation of genomic information in clinics. In addition, an increasing number of research projects related to the identification of chromosomal anomalies is anticipated to propel segment growth.

Transfection Reagents & Equipment Market Report Highlights:

  • The reagents segment dominated the transfection reagents and equipment market, with the largest revenue share of 55.4% in 2023.
  • The electroporation segment dominated the market in 2023. The broad selection of electroporation solutions from well-known and up-and-coming companies is driving growth in the segment.
  • The biomedical research segment is expected to register the fastest CAGR over the forecast period. In recent times, there has been a significant focus on the use of lentivirus for transfection in biomedical research.
  • North America dominated with largest revenue share in the transfection reagents and equipment market in 2023. The region is expected to continue this pattern in the forecast time frame.
  • Market participants are keen on expanding their product portfolios aimed at sustaining market competition.
  • For instance, in July 2019, Mirus Bio launched TransIT-VirusGEN SELECT Transfection Reagent, intended to be used in the drug discovery process in gene and cell manufacturing. The substance simplifies the qualifying process of ancillary materials employed in viral vectors manufacturing for preclinical and early-phase clinical trials.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Transfection Reagents and Equipment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Transfection Reagents and Equipment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Transfection Reagents and Equipment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transfection Reagents and Equipment Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Reagents
    • 4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Transfection Reagents and Equipment Market: Method Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transfection Reagents and Equipment Market: Method Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Electroporation
    • 5.3.1. Electroporation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Liposomes
    • 5.4.1. Liposomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Particle Bombardment
    • 5.5.1. Particle Bombardment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Microinjection
    • 5.6.1. Microinjection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Adenoviral Vectors
    • 5.7.1. Adenoviral Vectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Calcium Phosphate
    • 5.8.1. Calcium Phosphate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. DEAE-dextran
    • 5.9.1. DEAE-dextran Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Magnetic Beads
    • 5.10.1. Magnetic Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Activated Dendrimers
    • 5.11.1. Activated Dendrimers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.12. Laserfection
    • 5.12.1. Laserfection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Transfection Reagents and Equipment Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transfection Reagents and Equipment Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Gene Expression Studies
    • 6.3.1. Gene Expression Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Protein Production
    • 6.4.1. Protein Production Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Transgenic Models
    • 6.5.1. Transgenic Models Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Therapeutic Delivery
    • 6.6.1. Therapeutic Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Cancer Research
    • 6.7.1. Cancer Research Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Biomedical Research
    • 6.8.1. Biomedical Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Transfection Reagents and Equipment: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Transfection Reagents and Equipment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Academic and Research Institutes
    • 7.3.1. Academic and Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical and Biotechnological Companies
    • 7.4.1. Pharmaceutical and Biotechnological Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Transfection Reagents and Equipment: Regional Estimates & Trend Analysis

  • 8.1. Transfection Reagents and Equipment, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Transfection Reagents and Equipment Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 8.3.4. Italy
      • 8.3.4.1. Italy Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Spain
      • 8.3.5.1. Spain Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Denmark
      • 8.3.6.1. Denmark Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Sweden
      • 8.3.7.1. Sweden Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Norway
      • 8.3.8.1. Norway Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Transfection Reagents and Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Promega Corporation
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Lonza
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories Inc.
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Merck KGaA
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. OriGene Technologies Inc
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. MaxCyte, Inc.
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Polyplus
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives